Chronic graft-versus-host disease (GVHD) is a cause of late morbidity and mortality after allogeneic stem cell transplant.

Cancer therapies save lives but often cause neurologic damage, so we must recognize the full scope of neurotoxicity, from ...

Ianalumab significantly reduced disease activity in patients with Sjögren disease, according to results presented at the American College of Rheumatology (ACR) Convergence 2025.

There have been disturbing reports of substandard or falsified products causing harm to patients in a number of countries, ...

The number of people receiving treatment for cancer has risen dramatically in the last decade in many African countries. For ...

Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced achievement of ...